Supplier News

The company invested in a new cGMP facility located in Berlin, Germany.

PaizaBio will add aseptic injectable production capacity in Hangzhou, China.

Onset expanded its product line for pharmaceutical cold-chain management with the launch two new products.

R-Pharm Group, a private Russian pharmaceutical company, has opened a biopharmaceutical production plant in Yaroslavl, Russia, to produce biologics and biosimilars to treat autoimmune diseases and cancer. The facility, which has a line capacity is 2,000 L of cell culture per production cycle, is ready to be validated to US and Russia FDA and GMP requirements, the company reports.

GE Healthcare’s GE BioPark Cork will hold four KUBio manufacturing facilities; GE will also collaborate with NIBRT for biopharmaceutical training.

The project aims to address challenges facing the development, manufacture, and delivery of vaccines.

Catalent will acquire Pharmatek, a San Diego-based manufacturer of oral, injectable, and topical products.

Mumbai, the location for its new Indian subsidiary, will also be the site for the company's Uniquity Global Conference on October 6, 2016.

The company established a dedicated research center in Bangalore, India for Amgen.

The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.

CSafe completed the acquisition of Kallibox, a manufacturer of cold-chain packaging solutions.

The merger of Avantor Performance Materials and Nusil Technology positions the company for growth in bioprocessing.

GE and Sealed Air extend their long-term collaboration to develop single-use films purposefully constructed for bioprocessing applications.

The company is opening two offices in the United States that will offer serialization, automation, and process control services.

Irvine Scientific’s new product range includes chemically-defined, serum-free media, to increase productivity of viral vectors and recombinant proteins in suspension cultures.

Agilent Technologies announces plans to build a new oligo manufacturing facility in Colorado that will double current capacity.

FDA issued a warning letter to contract testing laboratory, Adamson Analytical Laboratories, for CGMP violations.

Catalent Pharma Solutions teamed with Zumutor Biologics to develop antibodies with enhanced ADCC activity.

MilliporeSigma will provide support to Y-mAbs for the development of its monoclonal antibody for the treatment of pediatric brain cancer.

The manufacturing subsidiary of Astellas Pharma in Oklahoma has been transferred to CMO Avara and renamed Avara Pharmaceutical Technologies.

Zenith appointed Carlos Machado as serialization director to lead the company’s sales, operations, and post project support services.

Curida will manufacture PCI Biotech’s Amphinex, a drug used to treat bile duct cancer.

A new website collects and rates information about life-science supplies from academic journals to simplify researcher purchasing decisions.

The company announced that it will be relaunching its customer collaboration centers.

The company plans to purchase and develop an 18-acre site in Des Plaines, Illinois.

GE further ramps up its cellular and gene therapy offerings with its acquisition of Biosafe, a cell processing solutions company.

UPS will expand its clinical trial logistics capabilities to include drug and vaccine development.

The company acquired kSep Holdings, a single-use bioprocessing solutions company.

The company will invest €100 million in the expansion of its Athlone facility.

The assay will provide information on biosimilar comparability.